Milind Deshpande
2010
In 2010, Milind Deshpande earned a total compensation of $907.1K as President, Research and Development and Chief Scientific Officer at Achillion Pharmaceuticals, a 68% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $116,000 |
|---|---|
| Option Awards | $454,000 |
| Salary | $329,436 |
| Other | $7,673 |
| Total | $907,109 |
Deshpande received $454K in option awards, accounting for 50% of the total pay in 2010.
Deshpande also received $116K in non-equity incentive plan, $329.4K in salary and $7.7K in other compensation.
Rankings
In 2010, Milind Deshpande's compensation ranked 5,665th out of 10,439 executives tracked by ExecPay. In other words, Deshpande earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,665 out of 10,439 | 46th |
Division Manufacturing | 2,051 out of 3,838 | 47th |
Major group Chemicals And Allied Products | 442 out of 921 | 52nd |
Industry group Drugs | 268 out of 680 | 61st |
Industry Pharmaceutical Preparations | 199 out of 481 | 59th |
Source: SEC filing on April 12, 2013.
Deshpande's colleagues
We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2010.
2010
Michael Kishbauch
Achillion Pharmaceuticals
Chief Executive Officer
2010
Joseph Truitt
Achillion Pharmaceuticals
Senior Vice President and Chief Commercial Officer
2010
Gautam Shah
Achillion Pharmaceuticals
Executive Vice President and Chief Compliance Officer
2010
Elizabeth Olek
Achillion Pharmaceuticals
Chief Medical Officer
2010
Mary Fenton
Achillion Pharmaceuticals